IL17A and psoriasis: In the IMQ-induced psoriasis mouse model, this approach reduced epidermal thickness, inhibited infiltration of CD3+ T cells and CD4+ T cells, lowered serum IL-17A and IFN-γ levels, and normalized spleen indices, demonstrating systemic anti-inflammatory effects [180].